Moreover, studies suggest that tissue plasminogen activator (tPA), a widely employed fibrinolytic agent in stroke therapy, is able to normalize microglial chemotaxis and phagocytosis through metabolic pathways’ modulation, including Akt and ERK 1/2 signaling (327, 328). The gene discussed is PLAT; the disease is stroke disorder.